WNDM Medical acquires remaining 50% interest in Cellerat, from Catalyst Group
In exchange of 50% stake, WNDM issued 1,136,815 shares of its newly created Series F convertible preferred stock.
Following the closing of this transaction, Ron Nixon, Founder and Managing Partner of CGI, was elected to WNDM’s board.
Date: March 25, 2019
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: Seeking Alpha